Canton Strategic Holdings, Inc. (CNTN)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$41.5M
Cash & Equivalents
$7.6M
Quarterly Burn Rate
16 mo
Est. Cash Runway
$225M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT05522205 Regulated Cannabis Access in Basel OTHER Active Not Recruiting 374

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for CNTN.

SEC EDGAR Filings

All SEC filings for Canton Strategic Holdings, Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.